Regulus Btn


Briefcase Shareholder Briefcase
Email Alerts E-Mail Alerts
Download Center Download Library
RSS News Feeds


(NASDAQ:ISIS) as of 4:12 PM ET on 05/13/02008
Last: 12.86 Change: $0.22 up  (1.74%)
Day High: 13.12 Day Low: 12.52


Recent Releases
05/12/08 Isis Reports Financial Results and Highlights for First Quarter of 2008
05/07/08 Webcast Alert: Isis Pharmaceuticals Announces First Quarter 2008 Financial Results Conference Call
05/06/08 Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases
 
Analyst Firm Phone
Debjit Chattopadhyay Boenning & Scattergood, Inc.   610-684-5417
Eric Schmidt Cowen and Co., LLC   646-562-1345
Geraldine O'Keeffe Fortis Securities LLC   31-20 527-9150
Salveen Kochnover Jefferies & Company, Inc.   212-284-2130
Joseph Schwartz Leerink Swann & Company   617-918-4575
Jim Birchenough Lehman Brothers Inc.   415-274-5393
Alex To Natixis Bleichroeder, Inc.   212-698-3146
Mark Monane Needham & Company   212-705-0346
Edward Tenthoff Piper Jaffray & Co.   212-284-9403
Carol Werther Summer Street Research Partners   617-532-6418
Aaron Reames Wachovia Capital Markets, LLC   617-603-4219

Contact Us
Kristina Lemonidis
Associate Director, Investor Relations

Telephone: 760-603-2331
E-mail: info@isisph.com